There is a great deal of work to do to eliminate cholera from the Global South, but progress is being made.
Researchers observed different functional states of the influenza virus polymerase as it is actively transcribing, providing valuable information for the next generation of anti-influenza drugs.
Researchers demonstrated that targeting a specific portion of the flu virus that varies little from strain to strain offers protection in humans.
Experts have said it may take years to contain African swine fever due to the differing biosecurity standards on commercial pig farms and backyard smallholdings across Asia.
Research demonstrated that a naturally occurring fungus engineered to deliver a toxin to mosquitoes safely reduced mosquito populations by more than 99 percent in a simulated village setting in Burkina Faso.
In a new study, remdesivir, an experimental antiviral drug, completely protected four African green monkeys from a lethal dose of Nipah virus,
The US Biomedical Advanced Research and Development Authority (BARDA) will procure Emergent BioSolutions’ anthrax vaccine into the Strategic National Stockpile. The plan is to deliver the vaccine into the Strategic National Stockpile in the second half of 2019.
Researchers at Rochester Clinical Research are helping to test a new smallpox vaccine.
A drone delivery network will distribute medicines, vaccines, and blood, to 2,000 clinics in remote parts of Ghana.
Over the next four years, the experiences of these countries will help the WHO determine if RTS,S can be effectively used, and whether it will deliver the nearly 40 percent decrease in malaria infections seen in an earlier Phase 3 clinical trial.To see whether a new malaria vaccine, RTS, is effective, the World Health Organization (WHO) and partners have devised a limited rollout of the vaccine in Malawi followed by Ghana and Kenya.